Cited by 2,684SARS-CoV-2 and COVID-19 ResearchRenin-Angiotensin System StudiesCOVID-19 Clinical Research Studies

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Open access
Zhang, Haibo, Penninger, Josef M., Li, Yimin, Zhong, Nanshan, Slutsky, Arthur S.·2020·Intensive Care Medicine

Abstract

A novel infectious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in Wuhan, China, in December 2019.The disease (COVID-19) spread rapidly, reaching epidemic proportions in China, and has been found in 27 other countries.As of February 27, 2020, over 82,000 cases of COVID-19 were reported, with > 2800 deaths.No specific therapeutics are available, and current management includes travel restrictions, patient isolation, and supportive medical care.There are a number of pharmaceuticals already being tested [1,2], but a better understanding of the underlying pathobiology is required.In this context, this article will briefly review the rationale for angiotensin-converting enzyme 2 (ACE2) receptor as a specific target.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00134-020-05985-9

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [5]https://www.nature.com/articles/d41586-020-00364-2

Cited by

Sorted by citations

Authors
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S.
Affiliations
  • St. Michael's Hospital (CA)
  • Institute of Molecular Biotechnology (AT)
  • First Affiliated Hospital of Guangzhou Medical University (CN)
Corresponding author
Slutsky, Arthur S.
Venue
Intensive Care Medicine
Published
2020-03-03
Volume
46
Issue
4
Pages
586-590
ISSN
  • 0342-4642 (ISSN-L)
  • 1432-1238
OpenAlex
W3010126769
Cited by
2,684
References
35
Citations by year
2026: 32 · 2025: 56 · 2024: 148 · 2023: 235 · 2022: 421 · 2021: 780 · 2020: 1008 · 2014: 1
FWCI
80.09
Type
journal article
Language
en
Open access
Locations
  • Intensive Care Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by-nc)
Funders
  • Institute of Circulatory and Respiratory Health (FDN143285)
  • "Natural Science Foundation of China" (81270125, 81490530, 2018GZR0201002)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
angiotensin-converting enzyme 2, ACE2, SARS-CoV-2, COVID-19 pandemic, viral receptor, receptor binding, therapeutic target, pathobiology
MeSH terms
Betacoronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Humans, Peptidyl-Dipeptidase A, Receptors, Virus, Respiratory Distress Syndrome, RNA, Viral, Viral Envelope Proteins, Severe Acute Respiratory Syndrome, Alveolar Epithelial Cells, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review